Case study

Net Present Value Assessment
for a Small Molecule Targeting
Chronic Kidney Disease


A US Biotech Startup


Perform commercial analytics on their lead asset and calculate the Net Present Value (NPV), and build patient share, and market share forecasts



Area of Focus

Chronic Kidney Disease

Key Questions
Our Solution

Built a dynamic model for patient and market share forecasts in US and EU5. Incorporated impact of competition and unmet medical need
Calculated the overall Net Present Value (NPV) of the asset with a dynamic model with different scenarios/base cases.

ArtiXio Advantage

Domain Experts

Commercial, Medical, Scientific

Proprietary Platform

Knowledgebase of Current Therapies and Unmet Need

Technology Suite

Dynamic Platform ArtTech

KOL Network

Models for NPV and Commercial Forecasting

Value Created

Value Created icon
A detailed forecast for their lead asset, with different base scenarios, along with the NPV that the startup used as a package for further fund-raising.
error: Content is protected !!